<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32737466</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-9985</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature structural &amp; molecular biology</Title><ISOAbbreviation>Nat Struct Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.</ArticleTitle><Pagination><StartPage>950</StartPage><EndPage>958</EndPage><MedlinePgn>950-958</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41594-020-0480-y</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently no approved therapies. We have isolated an antibody, EY6A, from an individual convalescing from COVID-19 and have shown that it neutralizes SARS-CoV-2 and cross-reacts with SARS-CoV-1. EY6A Fab binds the receptor binding domain (RBD) of the viral spike glycoprotein tightly (K<sub>D</sub> of 2&#x2009;nM), and a 2.6-&#xc5;-resolution crystal structure of an RBD-EY6A Fab complex identifies the highly conserved epitope, away from the ACE2 receptor binding site. Residues within this footprint are key to stabilizing the pre-fusion spike. Cryo-EM analyses of the pre-fusion spike incubated with EY6A Fab reveal a complex of the intact spike trimer with three Fabs bound and two further multimeric forms comprising the destabilized spike attached to Fab. EY6A binds what is probably a major neutralizing epitope, making it a candidate therapeutic for COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Daming</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Duyvesteyn</LastName><ForeName>Helen M E</ForeName><Initials>HME</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Cheng-Pin</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Guei</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ting-Hua</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Chien-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and National Yang-Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Shu-Hsing</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, and Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yhu-Chering</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tzou-Yien</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Che</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4741-2307</Identifier><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Jiandong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Rosalind Franklin Institute, Harwell Campus, Didcot, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Protein Production UK, Research Complex at Harwell, Harwell Science &amp; Innovation Campus, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrique</LastName><ForeName>Loic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malinauskas</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4847-5529</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruza</LastName><ForeName>Reinis R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Pranav N M</ForeName><Initials>PNM</Initials><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Tiong Kit</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0001-8746-8308</Identifier><AffiliationInfo><Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijal</LastName><ForeName>Pramila</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donat</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godwin</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Infection Service, Public Health England, Porton Down, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttigieg</LastName><ForeName>Karen R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>National Infection Service, Public Health England, Porton Down, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tree</LastName><ForeName>Julia A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>National Infection Service, Public Health England, Porton Down, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radecke</LastName><ForeName>Julika</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>Neil G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0003-4292-6971</Identifier><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supasa</LastName><ForeName>Piyada</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongkolsapaya</LastName><ForeName>Juthathip</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dengue Hemorrhagic Fever Research Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Screaton</LastName><ForeName>Gavin R</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0002-3549-4309</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Miles W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>National Infection Service, Public Health England, Porton Down, Salisbury, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert-Jaramillo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1268-2304</Identifier><AffiliationInfo><Affiliation>William Dunn School of Pathology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-8780-1630</Identifier><AffiliationInfo><Affiliation>William Dunn School of Pathology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-2506-1198</Identifier><AffiliationInfo><Affiliation>William Dunn School of Pathology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owens</LastName><ForeName>Raymond J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-3705-2993</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Rosalind Franklin Institute, Harwell Campus, Didcot, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Protein Production UK, Research Complex at Harwell, Harwell Science &amp; Innovation Campus, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naismith</LastName><ForeName>James H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-6744-5061</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Rosalind Franklin Institute, Harwell Campus, Didcot, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Protein Production UK, Research Complex at Harwell, Harwell Science &amp; Innovation Campus, Didcot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Alain R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0000-0001-9754-5303</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Yuguang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8916-8552</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jingshan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4015-1404</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>David I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0002-3426-4210</Identifier><AffiliationInfo><Affiliation>Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK. dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diamond Light Source Ltd, Harwell Science &amp; Innovation Campus, Didcot, UK. dave@strubi.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kuan-Ying A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0001-6891-6945</Identifier><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan. arthur1726@cgmh.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. arthur1726@cgmh.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>101122/Z/13/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N00065X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532/Z/09/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Struct Mol Biol</MedlineTA><NlmUniqueID>101186374</NlmUniqueID><ISSNLinking>1545-9985</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007140">Immunoglobulin Fab Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007140" MajorTopicYN="N">Immunoglobulin Fab Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32737466</ArticleId><ArticleId IdType="doi">10.1038/s41594-020-0480-y</ArticleId><ArticleId IdType="pii">10.1038/s41594-020-0480-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baud, D. et al. Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis. 20, 773 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32171390</ArticleId><ArticleId IdType="pmc">32171390</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(20)30195-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271&#x2013;280 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId><ArticleId IdType="pmc">32142651</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls, A. C. et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl Acad. Sci. USA 114, 11157&#x2013;11162 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29073020</ArticleId><ArticleId IdType="pmc">29073020</ArticleId><ArticleId IdType="doi">10.1073/pnas.1708727114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260&#x2013;1263 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId><ArticleId IdType="pmc">7164637</ArticleId><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, W., Gui, M., Wang, X. &amp; Xiang, Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 14, e1007236 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30102747</ArticleId><ArticleId IdType="pmc">30102747</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1007236</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls, A. C. et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281&#x2013;292 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">7102599</ArticleId><ArticleId IdType="pmc">7102599</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy, S. Dynamical asymmetry exposes 2019-nCoV prefusion spike. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/2020.04.20.052290v1 (2020).</Citation></Reference><Reference><Citation>Chen, X. et al. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell. Mol. Immunol. 17, 647&#x2013;649 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32313207</ArticleId><ArticleId IdType="pmc">32313207</ArticleId><ArticleId IdType="doi">10.1038/s41423-020-0426-7</ArticleId></ArticleIdList></Reference><Reference><Citation>ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, e237 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16796401</ArticleId><ArticleId IdType="pmc">16796401</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.0030237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui, J. et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl Acad. Sci. USA 101, 2536&#x2013;2541 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId><ArticleId IdType="pmc">14983044</ArticleId><ArticleId IdType="doi">10.1073/pnas.0307140101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Z. et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc. Natl Acad. Sci. USA 104, 12123&#x2013;12128 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17620608</ArticleId><ArticleId IdType="pmc">17620608</ArticleId><ArticleId IdType="doi">10.1073/pnas.0701000104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature https://doi.org/10.1038/s41586-020-2380-z (2020).</Citation></Reference><Reference><Citation>Shu, Y. &amp; McCauley, J. GISAID: global initiative on sharing all influenza data-from vision to reality. Euro Surveill. 22, 30494 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28382917</ArticleId><ArticleId IdType="pmc">28382917</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo, J. et al. Neutralization of SARS-CoV-2 by destruction of the prefusion spike. Cell Host Microbe https://doi.org/10.1016/j.chom.2020.06.010 (2020).</Citation></Reference><Reference><Citation>Yuan, M. et al. A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630&#x2013;633 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32245784</ArticleId><ArticleId IdType="pmc">32245784</ArticleId><ArticleId IdType="doi">10.1126/science.abb7269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382&#x2013;385 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32065055</ArticleId><ArticleId IdType="pmc">32065055</ArticleId><ArticleId IdType="doi">10.1080/22221751.2020.1729069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat. Commun. 11, 2251 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32366817</ArticleId><ArticleId IdType="pmc">32366817</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-16256-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist, N. R. Diagnostic Methods in Clinical Virology (Blackwell Scientific, 1966).</Citation></Reference><Reference><Citation>Huo, J. et al. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-020-0469-6 (2020).</Citation></Reference><Reference><Citation>Wrapp, D. et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181, 1004&#x2013;1015 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32375025</ArticleId><ArticleId IdType="pmc">32375025</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.04.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, Y. et al. Distinct conformational states of SARS-CoV-2 spike protein. Science https://doi.org/10.1126/science.abd4251 (2020).</Citation></Reference><Reference><Citation>Bloch, E. M. et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J. Clin. Invest. 130, 2757&#x2013;2765 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32254064</ArticleId><ArticleId IdType="pmc">32254064</ArticleId><ArticleId IdType="doi">10.1172/JCI138745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, C. et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323, 1582&#x2013;1589 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32219428</ArticleId><ArticleId IdType="pmc">7101507</ArticleId><ArticleId IdType="doi">10.1001/jama.2020.4783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv, Z. et al. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science https://doi.org/10.1126/science.abc5881 (2020).</Citation></Reference><Reference><Citation>Okba, N. M. A. et al. Early release-severe acute respiratory syndrome coronavirus 2&#x2013;specific antibody responses in coronavirus disease. Emerg. Infect. Dis. 26, 1478&#x2013;1488 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2607.200841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y. et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe https://doi.org/10.1016/j.chom.2020.04.023 (2020).</Citation></Reference><Reference><Citation>Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl Acad. Sci. USA 114, E7348&#x2013;E7357 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28807998</ArticleId><ArticleId IdType="pmc">28807998</ArticleId><ArticleId IdType="doi">10.1073/pnas.1707304114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, Y.-N. et al. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East. Emerg. Microbes Infect. 9, 1457&#x2013;1466 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32543353</ArticleId><ArticleId IdType="pmc">32543353</ArticleId><ArticleId IdType="doi">10.1080/22221751.2020.1782271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215&#x2013;220 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski, R. A. &amp; Swindells, M. B. LigPlot+: multiple ligand&#x2013;protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778&#x2013;2786 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21919503</ArticleId><ArticleId IdType="pmc">21919503</ArticleId><ArticleId IdType="doi">10.1021/ci200227u</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur Huang, K.-Y. et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat. Commun. 8, 762 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28970483</ArticleId><ArticleId IdType="pmc">28970483</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-00736-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettleship, J. E., Rahman-Huq, N. &amp; Owens, R. J. The production of glycoproteins by transient expression in mammalian cells. Methods Mol. Biol. 498, 245&#x2013;263 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18988030</ArticleId><ArticleId IdType="pmc">18988030</ArticleId><ArticleId IdType="doi">10.1007/978-1-59745-196-3_16</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">6988269</ArticleId></ArticleIdList></Reference><Reference><Citation>Caly, L. et al. Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med. J. Aust. 212, 459&#x2013;462 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32237278</ArticleId><ArticleId IdType="pmc">32237278</ArticleId><ArticleId IdType="doi">10.5694/mja2.50569</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;rber, G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Naunyn. Schmiedebergs. Arch. Exp. Pathol. Pharmakol. 162, 480&#x2013;483 (1931).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J. Appl. Crystallogr. 36, 308&#x2013;314 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0021889803001997</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D Biol. Crystallogr. 61, 651&#x2013;657 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15930615</ArticleId><ArticleId IdType="pmc">15930615</ArticleId><ArticleId IdType="doi">10.1107/S0907444905007808</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter, G. Xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186&#x2013;190 (2010).</Citation></Reference><Reference><Citation>Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. D Struct. Biol. 74, 85&#x2013;97 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29533234</ArticleId><ArticleId IdType="pmc">29533234</ArticleId><ArticleId IdType="doi">10.1107/S2059798317017235</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658&#x2013;674 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">2483472</ArticleId><ArticleId IdType="pmc">2483472</ArticleId><ArticleId IdType="doi">10.1107/S0021889807021206</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355&#x2013;367 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21460454</ArticleId><ArticleId IdType="pmc">21460454</ArticleId><ArticleId IdType="doi">10.1107/S0907444911001314</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley, P. &amp; Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126&#x2013;2132 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId><ArticleId IdType="pmc">15572765</ArticleId><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861&#x2013;877 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31588918</ArticleId><ArticleId IdType="pmc">31588918</ArticleId><ArticleId IdType="doi">10.1107/S2059798319011471</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30412051</ArticleId><ArticleId IdType="pmc">30412051</ArticleId><ArticleId IdType="doi">10.7554/eLife.42166</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1&#x2013;12 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26592709</ArticleId><ArticleId IdType="pmc">4711343</ArticleId><ArticleId IdType="doi">10.1016/j.jsb.2015.11.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani, A., Rubinstein, J. L., Fleet, D. J. &amp; Brubaker, M. A. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290&#x2013;296 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28165473</ArticleId><ArticleId IdType="pmc">28165473</ArticleId><ArticleId IdType="doi">10.1038/nmeth.4169</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart, D. I., Levine, M., Muirhead, H. &amp; Stammers, D. K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6&#x2009;&#xc5;. J. Mol. Biol. 134, 109&#x2013;142 (1979).</Citation><ArticleIdList><ArticleId IdType="pubmed">537059</ArticleId><ArticleId IdType="pmc">537059</ArticleId><ArticleId IdType="doi">10.1016/0022-2836(79)90416-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissinel, E. &amp; Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774&#x2013;797 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers, F. &amp; Higgins, D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 27, 135&#x2013;145 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28884485</ArticleId><ArticleId IdType="pmc">28884485</ArticleId><ArticleId IdType="doi">10.1002/pro.3290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouet, P., Robert, X. &amp; Courcelle, E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31, 3320&#x2013;3323 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12824317</ArticleId><ArticleId IdType="pmc">12824317</ArticleId><ArticleId IdType="doi">10.1093/nar/gkg556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>